Pharvaris PHVS
NASDAQ PHVS
$35.25 -0.41 (-1.15%)
As of: Sep 4, 2026 · 3:59 PM EDT

Pharvaris (PHVS) Current Leases (2021 - 2026)

Pharvaris' (PHVS) quarterly Current Leases came in at $241537.7 in Q1 2026, up 18.0% YoY from $204695.7 in Q1 2025, and up 3.64% on a QoQ basis from $233056.6 in Q4 2025.

Analysis

Pharvaris (PHVS) Current Leases (2021 - 2026) Analysis & Trends

Pharvaris (PHVS) has 6 years of Current Leases data on file, last reported at $241537.7 in Q1 2026.

  • Quarterly Current Leases rose 18.0% year-over-year to $241537.7 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $241537.7 (up 18.0% YoY) and the FY2025 annual result came in at $226202.9, down 6.04% from the prior year.
  • Current Leases rose to $241537.7 in Q1 2026, from $233056.6 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $248405.4 in Q2 2023 to a low of $104057.5 in Q2 2024.
  • A 5-year average of $179872.2 and a median of $191198.4 in 2022 frame the typical range for Current Leases.
  • Annual changes were most pronounced in 2023 — Current Leases surged 114.24% — and 2024, when it sank 58.11%.
  • Tracing PHVS's Current Leases over 5 years: stood at $191198.4 in 2022, then grew by 9.93% to $210175.2 in 2023, then advanced by 13.09% to $237684.5 in 2024, then decreased by 1.95% to $233056.6 in 2025, then increased by 3.64% to $241537.7 in 2026.
  • The last three Current Leases figures came in at $241537.7 (Q1 2026), $233056.6 (Q4 2025), and $160881.9 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 720.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 11.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 16.75 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 21.95 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 45.93 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.27 Mn
10 Pharvaris 2.10 Bn 1.73 Bn 85,072.10 223.63 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 223.63 Bn
Mar 31, 2026 241.54 Bn
Dec 31, 2025 233.06 Bn
Sep 30, 2025 160,881.85
Jun 30, 2025 182,861.30
Mar 31, 2025 204,695.66
Dec 31, 2024 237.68 Bn
Sep 30, 2024 109,205.85
Jun 30, 2024 104,057.49
Mar 31, 2024 130,864.22
Dec 31, 2023 210.18 Bn
Sep 30, 2023 -212,646.35
Jun 30, 2023 248.41 Bn
Mar 31, 2023 -244,850.74
Dec 31, 2022 191.20 Bn
Sep 30, 2022 113,216.10
Jun 30, 2022 118,200.00
Mar 31, 2022 114,289.89
Dec 31, 2021 113.75 Bn
Sep 30, 2021 -121,323.90